Innovation in transcatheter mitral valve interventions

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: S. Kodali, M. Urena

Summary

This comprehensive session presents the latest innovations in transcatheter mitral valve interventions, highlighting cutting-edge devices and clinical experiences. Topics include early feasibility studies of novel hemivalve systems, first-in-human experiences with new mitral valve replacement technologies, advances in transcatheter edge-to-edge repair (TEER) with one-year outcome data, and updates on the AltaValve programme for mitral annular calcification and transseptal mitral valve replacement.

Presentations available when logged in:

  • Update on the Early Feasibility Study with the MRace hemivalve to Reduce Mitral Regurgitation (EXPLORE MR)
  • First-in-human experience with Tioga Luna MVR system
  • Early human feasibility experience with the CARLEN system to treat functional mitral regurgitaion
  • AltaValve MAC programme update
  • AltaValve system TMVR programme update: first 100 transseptal patients